Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
MCRcI stem cells
- Development stage
- Phase 1
- Lead developer
- Honya Medical
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-coronary
01
Overview
MCRcI (Myo-Cardial Regenerative Cellular Injection) is an autologous stem cell therapy developed by Honya Medical for the treatment of cardiovascular diseases, specifically diffuse coronary artery disease (CAD) and heart failure. The therapy involves the mobilization of peripheral blood stem cells (typically using G-CSF), their collection via apheresis, and subsequent intra-coronary administration. The goal is to promote myocardial regeneration, improve left ventricular function, and enhance angiogenesis in ischemic cardiac tissue. The product is designed to address patients with diffuse CAD who may not be suitable candidates for traditional revascularization procedures like bypass surgery or stenting.
- Brand names
- MCRcI
- Other names
- Myo-Cardial Regenerative Cellular Injection
Beyond the preview
Go deeper on MCRcI stem cells.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on MCRcI stem cells.